A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four ...

Nintedanib treatment reduces the levels of circulating cancer antigen 125 in patients with progressive pulmonary fibrosis.

A new case report was published in Volume 13 of Oncoscienceon February 7, 2026, titled "Massive calcified solid ...

By adding ANPEP and PIGR to existing markers, researchers created a blood test that accurately identified early pancreatic ...

Pancreatic cancer is the 12th most common cancer worldwide. In 2022, there were 510,992 new cases of pancreatic cancer, with China, the US, and Japan reporting the highest number of cases globally.

The Gallbladder Cancer Foundation (GBCF), a non-profit dedicated to providing resources to patients & caregivers and funding research for one of the most aggressive forms of cancer, today announced a ...

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

Bile duct cancer is medically known as Cholangiocarcinoma. It refers to cancers that arise in the intrahepatic, perihilar, or distal biliary tree. Although it accounts for only about 3% of ...

PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. Many patients do not know they have the disease ...